EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Application of the TaqMan ARMS-PCR Approach for Genotyping Drug-Induced Hearing Loss Using Dried Blood Samples

Jiefeng Tan iD, Xiaoqing Zhang, Xue Wei, Min Ding

Current Issues in Molecular Biology · 29.05.2024 · 46 (6) · 5454-5466

DOI: 10.3390/cimb46060326 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Current Issues in Molecular Biology, online erschienen am 29.05.2024. Verfasst von Jiefeng Tan und 3 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Clinical Laboratory Diagnostics, Ministry of Education of China, School of Laboratory Medicine, Chongqing Medical University, Chong…. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation Project of Chongqing.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A single nucleotide variant in mitochondrial DNA (mtDNA) 1555A>G is associated with drug-induced hearing loss. For the 1555A>G mutation site, 1555A wild-type and 1555G mutant-type plasmids were constructed, respectively. In this study, a PCR method based on the TaqMan amplification refractory mutation system was proposed to detect mtDNA 1555A>G. A common upstream primer, a common TaqMan probe, and two downstream allele-specific primers with mismatched bases were designed. One-step amplification and detection of the wild-type and mutant type at the 1555 site were realized for the deafness-related gene through two reactions. Based on this detection method, the minimum detection limit of the wild-type and mutant type detection systems for plasmids was 50 copies/μL. The minimum sensitivity for the detection of nucleic acids in real dried blood spot (DBS) samples was 0.1 ng/μL. In the normal DBS DNA sample, the detection limit of the mutation abundance reached 0.78%. The specificity of the detection method was 100%, and the coefficient of variation was less than 3.36%. This approach was validated using clinical DNA extracted from 113 DBS samples of newborns. Additionally, it showed 100% agreement with bi-directional Sanger sequencing. It can be used as an optional method for the clinical detection of deafness-related genes.

Schlagwörter

Stichwörter der Autor:innen

amplification refractory mutation systemdeafnessgenotypingnucleic acid detectionsingle nucleotide polymorphism

Autor:innen und Institutionen

  • Key Laboratory of Clinical Laboratory Diagnostics, Ministry of Education of China, School of Laboratory Medicine, Chongqing Medical University, Chongqing 400016, China.

ORCID-Profile: Jiefeng Tan

Förderung

  • Natural Science Foundation Project of Chongqing

Zitieren

APA

Tan, J., Zhang, X., Wei, X., & Ding, M. (2024). Application of the TaqMan ARMS-PCR Approach for Genotyping Drug-Induced Hearing Loss Using Dried Blood Samples. Current Issues in Molecular Biology, 46(6), 5454-5466. https://doi.org/10.3390/cimb46060326

Vancouver

Tan J, Zhang X, Wei X, Ding M. Application of the TaqMan ARMS-PCR Approach for Genotyping Drug-Induced Hearing Loss Using Dried Blood Samples. Current Issues in Molecular Biology. 2024;46(6):5454-5466. doi:10.3390/cimb46060326

BibTeX
@article{Tan2024,
  author = {Tan, Jiefeng and Zhang, Xiaoqing and Wei, Xue and Ding, Min},
  title = {Application of the TaqMan ARMS-PCR Approach for Genotyping Drug-Induced Hearing Loss Using Dried Blood Samples},
  journal = {Current Issues in Molecular Biology},
  year = {2024},
  volume = {46},
  number = {6},
  pages = {5454--5466},
  doi = {10.3390/cimb46060326}
}
Kostenlos starten →